Kurt Stocker: Katalogdaten im Herbstsemester 2023 |
| Name | Herr PD Dr. Kurt Stocker |
| Adresse | Lehre Geistes-,Soz.-u.Staatswiss. ETH Zürich, RZ E 22.2 Clausiusstrasse 59 8092 Zürich SWITZERLAND |
| Telefon | +41 44 632 23 35 |
| kurt.stocker@gess.ethz.ch | |
| Departement | Geistes-, Sozial- und Staatswissenschaften |
| Beziehung | Dozent |
| Nummer | Titel | ECTS | Umfang | Dozierende | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 851-0251-00L | Psychedelic Science: Psychology, Pharmacology, Physiology Psychotherapy, Philosophy  | 3 KP | 2V | K. Stocker | ||||||||
| Kurzbeschreibung | This lecture series covers psychedelic science mainly psychologically, and additionally pharmacologically, physiologically, psychiatrically/psychotherapeutically, and philosophically. All contributions will also be reflected on from the viewpoint of the humanities and psychology. | |||||||||||
| Lernziel | To provide students with a multidisciplinary introduction to psychedelic science, and to also comprehensively embed this in a reflection from a humanities/psychology viewpoint. | |||||||||||
| Inhalt | Psychedelic science is a multidisciplinary field of study that involves scholars of the mind and scholars of the natural sciences. In this course, psychedelic science is presented mainly from the point of view of psychology, but will additionally also be considered from the viewpoints of pharmacology, physiology, psychiatrypsychotherapy, and philosophy. All non-psychological contributions will also be reflected on from the viewpoint of the humanities and psychology. The psychedelic studies treated in this course that involve humans focus on controlled and ethically approved studies where these substances are administered to medically screened, prepared, and supported participants. Privateillicit use of psychedelics is not a topic of this course. A psychedelic experience can be characterized as a temporary nonordinary state of consciousness (NSC) that is occasioned by classic (serotonergic) psychedelics such as psilocybin, mescaline, N,N-dimethyltryptamine (DMT), and lysergic acid diethylamide (LSD). Psychologically, the psychedelic experience can mainly manifest at the perceptual, cognitive, affective, volitional, and somesthetic level. The nonordinary perceptual spectrum ranges from visions (e.g., patterns or beings) to the subjective experience of an all-encompassing oneness, which also transcends the distinction between the perceiver and the perceived. The nonordinary cognitive spectrum ranges from no longer functionable thinking to very clear thinking, the nonordinary affective spectrum, for example, from deepest sadness to highest bliss, the nonordinary volitional spectrum from the feeling of being able to somewhat influence what is happening to the feeling of having no longer a will of one’s own, and the nonordinary somesthetic spectrum, for example, from feelings of bodily heavinesscompression to feelings of bodily lightnessfloating. Heuristically, as one possibility, a psychological typology of the psychedelic experience can be characterized to fall into three main types religious-like experiences (which may be interpreted religiouslyspiritually by the individuals having them, but may also be interpreted materialistically or agnostically), autobiographical experiences, and tripartite-mind (cognitionaffectconation) miscellaneous experiences. Investigating the psychedelic experience is a worthwhile endeavor as, for instance, certain aspects of this experience have been associated with increased subjective well-being both for healthy individuals as well as for patients – for example, persisting positive effects on attitudes, mood, and behavior in healthy individuals and sustained symptom reduction in individuals suffering from depression, anxiety, and addiction. Psychedelic science is overall a large multidisciplinary effort that requires collaboration of scholars of the mind and scholars of the natural sciences to advance the scientific knowledge of it. In this spirit, this course will – besides the main lecturer (PD Dr. phil. Kurt Stocker, a psychologist) – also involve further psychedelic-scientific scholars giving individual lectures in their respective field of expertise psychology (PD Dr. phil. Katrin Preller, University of Zurich & Yale University), pharmacology (Dr. phil. nat. Dino Luethi, University Hospital Basel; Dr. phil. nat. Deborah Rudin, University Hospital Basel; Prof. Dr. phil. Linda Simmler, University of Basel), physiology (PD Dr. sc. nat. Felix Scholkmann, University of Zurich & University of Bern), psychiatrypsychotherapy (Prof. Dr. med. Gregor Hasler, University of Fribourg; Dr. med. Dr. sc. ETH Milan Scheidegger, University of Zurich), and philosophy (Dr. Peter Sjöstedt-Hughes, University of Exeter). Overall, this course will provide an informative overview of the research foundations that have made psychedelic science what it is today, and will also provide an identification of the research frontiers that must be addressed to expand the psychedelic science of tomorrow. | |||||||||||
Kompetenzen |
| |||||||||||